Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vincent

Showing results (911-920 of 968) with videos related to

Pageof 97
Sort By:
American Journal of Hematology|March 5, 2020
Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemiaLaura A Evans, Dragan Jevremovic, Bharat Nandakumar, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 27, 2021
Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance (MGRS)-Associated Lesions: A Case SeriesCihan Heybeli, Mariam Priya Alexander, Andrew J Bentall, et al.
Blood Cancer Journal|December 14, 2020
Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patientsAlissa Visram, Abdullah S Al Saleh, Harsh Parmar, et al.
American Journal of Hematology|October 28, 2021
Prognostic significance of acquired 1q22 gain in multiple myelomaHadiyah Y Audil, Joselle M Cook, Patricia T Greipp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statementMeletios A Dimopoulos, Jens Hillengass, Saad Usmani, et al.
Blood Advances|May 23, 2020
Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myelomaPatrick W Mellors, Moritz Binder, Rhett P Ketterling, et al.
Blood Cancer Journal|September 29, 2025
Impact of residual clonal plasma cells in S-phase at the time of autologous stem cell transplantation on clinical outcomesTamer Hellou, Daniel G Packard, Suheil Albert Atallah-Yunes, et al.
Blood Cancer Journal|October 17, 2020
International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)María-Victoria Mateos, Shaji Kumar, Meletios A Dimopoulos, et al.
Blood Cancer Journal|March 9, 2019
Natural history of multiple myeloma with de novo del(17p)Arjun Lakshman, Utkarsh Painuly, S Vincent Rajkumar, et al.
American Journal of Hematology|October 13, 2022
Risk factors for severe infection and mortality In patients with COVID-19 in patients with multiple myeloma and AL amyloidosisMatthew Ho, Saurabh Zanwar, Francis K Buadi, et al.
Pageof 97

Showing results (911-920 of 968) with videos related to

Sort By:
Pageof 97
American Journal of Hematology|March 5, 2020
Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemiaLaura A Evans, Dragan Jevremovic, Bharat Nandakumar, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 27, 2021
Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance (MGRS)-Associated Lesions: A Case SeriesCihan Heybeli, Mariam Priya Alexander, Andrew J Bentall, et al.
Blood Cancer Journal|December 14, 2020
Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patientsAlissa Visram, Abdullah S Al Saleh, Harsh Parmar, et al.
American Journal of Hematology|October 28, 2021
Prognostic significance of acquired 1q22 gain in multiple myelomaHadiyah Y Audil, Joselle M Cook, Patricia T Greipp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statementMeletios A Dimopoulos, Jens Hillengass, Saad Usmani, et al.
Blood Advances|May 23, 2020
Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myelomaPatrick W Mellors, Moritz Binder, Rhett P Ketterling, et al.
Blood Cancer Journal|September 29, 2025
Impact of residual clonal plasma cells in S-phase at the time of autologous stem cell transplantation on clinical outcomesTamer Hellou, Daniel G Packard, Suheil Albert Atallah-Yunes, et al.
Blood Cancer Journal|October 17, 2020
International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)María-Victoria Mateos, Shaji Kumar, Meletios A Dimopoulos, et al.
Blood Cancer Journal|March 9, 2019
Natural history of multiple myeloma with de novo del(17p)Arjun Lakshman, Utkarsh Painuly, S Vincent Rajkumar, et al.
American Journal of Hematology|October 13, 2022
Risk factors for severe infection and mortality In patients with COVID-19 in patients with multiple myeloma and AL amyloidosisMatthew Ho, Saurabh Zanwar, Francis K Buadi, et al.
Pageof 97